These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35018749)

  • 1. Assessing and managing people with sickle cell disease presenting with vaso-occlusive crisis in the emergency department.
    De D; Thakur I
    Emerg Nurse; 2022 May; 30(3):33-40. PubMed ID: 35018749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Interrupted Time Series Analysis of the Dissemination of a Sickle Cell Vaso-Occlusive Episode Treatment Algorithm and a Case Management Referral Form for Individuals With Sickle Cell Disease in the Emergency Department.
    Bulgin D; Bonnabeau E; Alexander A; Frederick E; Rains G; Shah N; Young M; Tanabe P
    J Emerg Nurs; 2021 Jan; 47(1):40-49.e1. PubMed ID: 32826064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sickle cell disease in the emergency department.
    Lovett PB; Sule HP; Lopez BL
    Emerg Med Clin North Am; 2014 Aug; 32(3):629-47. PubMed ID: 25060254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sickle Cell Disease in the Emergency Department.
    Lovett PB; Sule HP; Lopez BL
    Hematol Oncol Clin North Am; 2017 Dec; 31(6):1061-1079. PubMed ID: 29078924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An innovative short-stay health care model for treatment of uncomplicated vaso-occlusive crisis in adult sickle cell disease patients in Canada to reduce emergency department utilization.
    Binding A; Ward R; Phua C; Naessens V; O'Brien T; Bhatia S; Baranek H; Marani H; Mukerji G
    CJEM; 2019 Jan; 21(1):55-62. PubMed ID: 29039292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactate Dehydrogenase: A Marker of the Severity of Vaso-Occlusive Crisis in Children with Sickle Cell Disease Presenting at the Emergency Department.
    García-Morin M; López-Sangüos C; Vázquez P; Alvárez T; Marañón R; Huerta J; Cela E
    Hemoglobin; 2016 Nov; 40(6):388-391. PubMed ID: 28361592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exacerbation of oxidative stress during sickle vaso-occlusive crisis is associated with decreased anti-band 3 autoantibodies rate and increased red blood cell-derived microparticle level: a prospective study.
    Hierso R; Lemonne N; Villaescusa R; Lalanne-Mistrih ML; Charlot K; Etienne-Julan M; Tressières B; Lamarre Y; Tarer V; Garnier Y; Hernandez AA; Ferracci S; Connes P; Romana M; Hardy-Dessources MD
    Br J Haematol; 2017 Mar; 176(5):805-813. PubMed ID: 27984639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of short-term emergency department observation care of children with sickle cell disease and vaso-occlusive crises: initial experience from south-western Nigeria.
    Adegoke SA; Oladimeji OI; Ologun BG; Aladekomo TA; Oyelami OA
    Trans R Soc Trop Med Hyg; 2020 May; 114(5):365-371. PubMed ID: 32181486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Home Management and Prevention of Vaso-Occlusive Crisis of Sickle Cell Disease Knowledge among Nursing Students.
    Hamid HIA; Shanmugam AJ; Alnassry SMA; Abdelgader AAM; Bashir WAH; Ali MAA; Madhappan A
    J Pain Palliat Care Pharmacother; 2023 Jun; 37(2):157-163. PubMed ID: 36912810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
    Krishnamoorthy P; Alyaarubi S; Abish S; Gale M; Albuquerque P; Jabado N
    Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous magnesium for pediatric sickle cell vaso-occlusive crisis: methodological issues of a randomized controlled trial.
    Badaki-Makun O; Scott JP; Panepinto JA; Casper TC; Hillery CA; Dean JM; Brousseau DC;
    Pediatr Blood Cancer; 2014 Jun; 61(6):1049-54. PubMed ID: 24443249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does e-pain plan improve management of sickle cell disease associated vaso-occlusive pain crisis? a mixed methods evaluation.
    Kato-Lin YC; Krishnamurti L; Padman R; Seltman HJ
    Int J Med Inform; 2014 Nov; 83(11):814-24. PubMed ID: 25179666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to pain relief: A randomized controlled trial in the emergency department during vaso-occlusive episodes in sickle cell disease.
    Tanabe P; Bosworth HB; Crawford RD; Glassberg J; Miller CN; Paice JA; Silva S
    Eur J Haematol; 2023 May; 110(5):518-526. PubMed ID: 36602417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease.
    van Zuuren EJ; Fedorowicz Z
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD010155. PubMed ID: 26684281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
    Ender KL; Krajewski JA; Babineau J; Tresgallo M; Schechter W; Saroyan JM; Kharbanda A
    Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute kidney injury during a pediatric sickle cell vaso-occlusive pain crisis.
    Baddam S; Aban I; Hilliard L; Howard T; Askenazi D; Lebensburger JD
    Pediatr Nephrol; 2017 Aug; 32(8):1451-1456. PubMed ID: 28238158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addressing challenges of clinical trials in acute pain: The Pain Management of Vaso-occlusive Crisis in Children and Young Adults with Sickle Cell Disease Study.
    Nottage KA; Hankins JS; Faughnan LG; James DM; Richardson J; Christensen R; Kang G; Smeltzer M; Cancio MI; Wang WC; Anghelescu DL
    Clin Trials; 2016 Aug; 13(4):409-16. PubMed ID: 27000103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the Care of Individuals With Sickle Cell Disease in the Emergency Department Using a Quality Improvement Framework: The Emergency Department Sickle Cell Assessment of Needs and Strengths (ED-SCANS).
    Brennan-Cook J; Bonnabeau E; Harris-Bloom H; Tanabe P
    Adv Emerg Nurs J; 2019; 41(3):261-270. PubMed ID: 31356252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sickle cell disease: healthcare professionals' views of patients in the emergency department.
    Jerman H; Chang YS
    Emerg Nurse; 2024 Apr; 32(3):22-27. PubMed ID: 37580998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary cross-linked carboxyterminal telopeptide, a bone resorption marker, decreases after vaso-occlusive crises in adults with sickle cell disease.
    Adesina OO; Jenkins IC; Wu QV; Fung EB; Narla RR; Lipkin EW; Mahajan K; Konkle BA; Kruse-Jarres R
    Blood Cells Mol Dis; 2020 Feb; 80():102369. PubMed ID: 31677454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.